Gresham Richter
Concepts (489)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Malformations | 22 | 2023 | 98 | 8.160 |
Why?
| Arteriovenous Malformations | 16 | 2023 | 67 | 7.160 |
Why?
| Hemangioma | 14 | 2022 | 83 | 5.760 |
Why?
| Propranolol | 10 | 2020 | 78 | 3.260 |
Why?
| Lymphatic Abnormalities | 7 | 2020 | 22 | 3.230 |
Why?
| Glottis | 8 | 2020 | 32 | 3.160 |
Why?
| Laryngomalacia | 9 | 2016 | 24 | 3.050 |
Why?
| Infant | 50 | 2021 | 3567 | 2.320 |
Why?
| Neck | 11 | 2022 | 99 | 2.240 |
Why?
| Child | 53 | 2023 | 6847 | 2.050 |
Why?
| Sclerotherapy | 11 | 2023 | 45 | 2.030 |
Why?
| Lasers, Solid-State | 5 | 2020 | 32 | 1.960 |
Why?
| Child, Preschool | 43 | 2022 | 3871 | 1.870 |
Why?
| Laryngoscopy | 10 | 2020 | 58 | 1.850 |
Why?
| Laryngostenosis | 4 | 2020 | 11 | 1.840 |
Why?
| Deglutition Disorders | 5 | 2017 | 77 | 1.820 |
Why?
| Humans | 115 | 2023 | 49974 | 1.810 |
Why?
| Laser Therapy | 6 | 2020 | 84 | 1.610 |
Why?
| Treatment Outcome | 33 | 2023 | 5141 | 1.570 |
Why?
| Vascular Surgical Procedures | 5 | 2020 | 165 | 1.480 |
Why?
| Tonsillectomy | 4 | 2021 | 49 | 1.340 |
Why?
| Larynx | 7 | 2017 | 30 | 1.330 |
Why?
| Veins | 6 | 2023 | 71 | 1.330 |
Why?
| Hemangioma, Capillary | 2 | 2020 | 12 | 1.290 |
Why?
| Male | 66 | 2021 | 25241 | 1.270 |
Why?
| Embolization, Therapeutic | 6 | 2023 | 88 | 1.250 |
Why?
| Female | 65 | 2022 | 26472 | 1.180 |
Why?
| Retrospective Studies | 32 | 2022 | 6108 | 1.150 |
Why?
| Otolaryngology | 4 | 2021 | 55 | 1.140 |
Why?
| Head | 5 | 2022 | 73 | 1.120 |
Why?
| Skin | 5 | 2020 | 409 | 1.070 |
Why?
| Trachea | 5 | 2018 | 52 | 0.970 |
Why?
| Facial Neoplasms | 2 | 2017 | 22 | 0.920 |
Why?
| Tongue | 4 | 2023 | 39 | 0.910 |
Why?
| Ambulatory Surgical Procedures | 2 | 2021 | 46 | 0.910 |
Why?
| Vocal Cord Paralysis | 2 | 2022 | 22 | 0.910 |
Why?
| Head and Neck Neoplasms | 5 | 2015 | 268 | 0.900 |
Why?
| Otorhinolaryngologic Diseases | 2 | 2014 | 11 | 0.890 |
Why?
| Cell Proliferation | 7 | 2023 | 1007 | 0.870 |
Why?
| Collagen | 2 | 2019 | 206 | 0.870 |
Why?
| Adolescent | 27 | 2022 | 6356 | 0.870 |
Why?
| Face | 2 | 2020 | 60 | 0.840 |
Why?
| Health Information Systems | 1 | 2022 | 20 | 0.830 |
Why?
| Respiratory Aspiration | 2 | 2014 | 9 | 0.820 |
Why?
| Surgery, Computer-Assisted | 2 | 2020 | 55 | 0.820 |
Why?
| Adrenergic beta-Antagonists | 4 | 2020 | 102 | 0.810 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2013 | 78 | 0.810 |
Why?
| Hyperpigmentation | 1 | 2021 | 10 | 0.800 |
Why?
| Cricoid Cartilage | 2 | 2020 | 11 | 0.790 |
Why?
| Receptors, Progesterone | 1 | 2021 | 63 | 0.750 |
Why?
| Otorhinolaryngologic Surgical Procedures | 3 | 2014 | 34 | 0.750 |
Why?
| Graft Survival | 4 | 2011 | 150 | 0.740 |
Why?
| Intracranial Arteriovenous Malformations | 2 | 2019 | 29 | 0.730 |
Why?
| Ambulatory Care Facilities | 1 | 2021 | 125 | 0.730 |
Why?
| Dermatologic Surgical Procedures | 1 | 2020 | 34 | 0.730 |
Why?
| Dilatation | 2 | 2017 | 26 | 0.730 |
Why?
| Receptors, Estrogen | 1 | 2021 | 130 | 0.730 |
Why?
| Prospective Studies | 8 | 2022 | 2364 | 0.710 |
Why?
| Risk Assessment | 10 | 2018 | 1259 | 0.710 |
Why?
| Infant, Newborn | 19 | 2020 | 2772 | 0.700 |
Why?
| Tracheostomy | 3 | 2022 | 75 | 0.680 |
Why?
| Elastin | 1 | 2019 | 23 | 0.670 |
Why?
| Inpatients | 1 | 2021 | 190 | 0.670 |
Why?
| Vasodilator Agents | 2 | 2017 | 96 | 0.670 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1032 | 0.670 |
Why?
| Gastroesophageal Reflux | 2 | 2017 | 49 | 0.660 |
Why?
| Skin Transplantation | 3 | 2009 | 43 | 0.660 |
Why?
| Follow-Up Studies | 12 | 2018 | 2182 | 0.650 |
Why?
| Thyroid Cartilage | 1 | 2018 | 2 | 0.640 |
Why?
| Vascular Endothelial Growth Factor A | 3 | 2009 | 201 | 0.640 |
Why?
| Laryngoplasty | 1 | 2018 | 7 | 0.640 |
Why?
| Pharynx | 3 | 2014 | 33 | 0.640 |
Why?
| Vascular Neoplasms | 1 | 2018 | 17 | 0.630 |
Why?
| Mast Cells | 1 | 2018 | 52 | 0.630 |
Why?
| Endoscopy | 6 | 2015 | 124 | 0.620 |
Why?
| Ki-67 Antigen | 3 | 2013 | 57 | 0.610 |
Why?
| Endovascular Procedures | 1 | 2020 | 173 | 0.610 |
Why?
| Respiratory Tract Infections | 2 | 2020 | 75 | 0.600 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 107 | 0.590 |
Why?
| Disease Models, Animal | 2 | 2013 | 1455 | 0.590 |
Why?
| Deglutition | 3 | 2014 | 42 | 0.590 |
Why?
| Eosinophilic Esophagitis | 1 | 2017 | 34 | 0.580 |
Why?
| Young Adult | 12 | 2022 | 3958 | 0.580 |
Why?
| Rectum | 1 | 2017 | 54 | 0.580 |
Why?
| Estradiol | 1 | 2018 | 225 | 0.580 |
Why?
| Vagina | 1 | 2017 | 45 | 0.570 |
Why?
| Receptors, Adrenergic, beta | 1 | 2017 | 42 | 0.570 |
Why?
| Renin-Angiotensin System | 1 | 2017 | 58 | 0.570 |
Why?
| Laryngeal Neoplasms | 2 | 2015 | 42 | 0.570 |
Why?
| Bleomycin | 3 | 2022 | 35 | 0.560 |
Why?
| Ultrasonography, Prenatal | 1 | 2018 | 188 | 0.560 |
Why?
| Nasopharynx | 2 | 2020 | 25 | 0.550 |
Why?
| Adult | 22 | 2022 | 13236 | 0.550 |
Why?
| Cerebral Palsy | 2 | 2014 | 40 | 0.540 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2016 | 57 | 0.540 |
Why?
| Skin Neoplasms | 2 | 2022 | 488 | 0.530 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2016 | 88 | 0.530 |
Why?
| Sleep Apnea, Obstructive | 2 | 2014 | 67 | 0.520 |
Why?
| Hearing Aids | 5 | 2017 | 67 | 0.520 |
Why?
| Wound Healing | 2 | 2014 | 204 | 0.510 |
Why?
| Blood Coagulation Disorders | 3 | 2020 | 33 | 0.500 |
Why?
| Blotting, Western | 4 | 2021 | 601 | 0.490 |
Why?
| Alginates | 1 | 2014 | 8 | 0.490 |
Why?
| Skin Ulcer | 1 | 2014 | 9 | 0.490 |
Why?
| Polysaccharides | 1 | 2014 | 50 | 0.470 |
Why?
| Postoperative Complications | 3 | 2021 | 984 | 0.470 |
Why?
| Silver | 1 | 2014 | 46 | 0.470 |
Why?
| Adenoidectomy | 2 | 2020 | 35 | 0.470 |
Why?
| Organophosphonates | 1 | 2013 | 7 | 0.460 |
Why?
| Periodicals as Topic | 1 | 2014 | 58 | 0.450 |
Why?
| Cytosine | 1 | 2013 | 30 | 0.450 |
Why?
| RNA, Messenger | 4 | 2022 | 1105 | 0.440 |
Why?
| Signal Transduction | 3 | 2020 | 1618 | 0.440 |
Why?
| Nervous System Diseases | 1 | 2014 | 88 | 0.440 |
Why?
| Palate | 1 | 2013 | 12 | 0.440 |
Why?
| Uvula | 1 | 2013 | 14 | 0.440 |
Why?
| Pharyngeal Diseases | 1 | 2013 | 14 | 0.430 |
Why?
| Choristoma | 1 | 2013 | 23 | 0.430 |
Why?
| Endothelial Cells | 3 | 2023 | 269 | 0.430 |
Why?
| Infant, Premature, Diseases | 1 | 2013 | 94 | 0.430 |
Why?
| Thymus Gland | 1 | 2013 | 42 | 0.420 |
Why?
| Gestational Age | 2 | 2013 | 421 | 0.420 |
Why?
| Surgical Flaps | 2 | 2020 | 119 | 0.420 |
Why?
| Quality of Life | 3 | 2014 | 836 | 0.410 |
Why?
| Receptors, Cell Surface | 1 | 2013 | 122 | 0.410 |
Why?
| Milk Hypersensitivity | 1 | 2012 | 19 | 0.410 |
Why?
| Sclerosing Solutions | 2 | 2022 | 14 | 0.410 |
Why?
| Down Syndrome | 1 | 2013 | 91 | 0.410 |
Why?
| Pilot Projects | 4 | 2019 | 699 | 0.410 |
Why?
| Lymphangioma, Cystic | 1 | 2011 | 10 | 0.400 |
Why?
| Endothelium, Lymphatic | 1 | 2011 | 12 | 0.400 |
Why?
| Antigens, CD | 1 | 2013 | 219 | 0.400 |
Why?
| Clinical Competence | 3 | 2020 | 393 | 0.390 |
Why?
| Laryngeal Diseases | 2 | 2010 | 12 | 0.390 |
Why?
| Milk Proteins | 1 | 2012 | 78 | 0.390 |
Why?
| Mouth | 2 | 2010 | 33 | 0.390 |
Why?
| Microtubule-Associated Proteins | 1 | 2011 | 67 | 0.390 |
Why?
| Papillomavirus Infections | 1 | 2013 | 155 | 0.390 |
Why?
| Tracheoesophageal Fistula | 2 | 2008 | 9 | 0.390 |
Why?
| Homeodomain Proteins | 1 | 2011 | 80 | 0.380 |
Why?
| Laryngeal Mucosa | 1 | 2011 | 4 | 0.380 |
Why?
| Nervous System Physiological Phenomena | 1 | 2010 | 9 | 0.380 |
Why?
| Laryngeal Nerves | 1 | 2011 | 16 | 0.380 |
Why?
| Tumor Suppressor Proteins | 1 | 2011 | 128 | 0.380 |
Why?
| Severity of Illness Index | 6 | 2014 | 945 | 0.380 |
Why?
| Magnetic Resonance Angiography | 3 | 2018 | 77 | 0.370 |
Why?
| Osseointegration | 3 | 2017 | 32 | 0.370 |
Why?
| Neuromuscular Diseases | 1 | 2011 | 30 | 0.370 |
Why?
| Hospitals, Special | 1 | 2010 | 9 | 0.360 |
Why?
| Capillaries | 2 | 2022 | 50 | 0.360 |
Why?
| Airway Obstruction | 3 | 2018 | 47 | 0.360 |
Why?
| Cholesteatoma, Middle Ear | 2 | 2009 | 32 | 0.360 |
Why?
| Cheek | 1 | 2010 | 9 | 0.360 |
Why?
| Lip | 1 | 2010 | 11 | 0.350 |
Why?
| Tracheal Neoplasms | 1 | 2009 | 8 | 0.350 |
Why?
| Multiple Endocrine Neoplasia Type 2a | 1 | 2009 | 5 | 0.340 |
Why?
| Cicatrix | 2 | 2020 | 40 | 0.340 |
Why?
| Immunohistochemistry | 4 | 2015 | 973 | 0.340 |
Why?
| Carcinoma, Medullary | 1 | 2009 | 12 | 0.340 |
Why?
| Consensus | 3 | 2020 | 148 | 0.340 |
Why?
| Proteus mirabilis | 1 | 2009 | 2 | 0.340 |
Why?
| Proteus Infections | 1 | 2009 | 4 | 0.340 |
Why?
| Bacteroidaceae Infections | 1 | 2009 | 4 | 0.340 |
Why?
| Electrocoagulation | 2 | 2009 | 12 | 0.340 |
Why?
| Bacteroides | 1 | 2009 | 14 | 0.340 |
Why?
| Brain Abscess | 1 | 2009 | 12 | 0.340 |
Why?
| Otitis Media, Suppurative | 1 | 2009 | 9 | 0.330 |
Why?
| Cerebellar Diseases | 1 | 2009 | 17 | 0.330 |
Why?
| Combined Modality Therapy | 5 | 2018 | 637 | 0.330 |
Why?
| Proto-Oncogene Proteins c-ret | 1 | 2009 | 33 | 0.330 |
Why?
| Quality Improvement | 2 | 2021 | 208 | 0.330 |
Why?
| Vomiting | 2 | 2021 | 75 | 0.330 |
Why?
| Child Development | 1 | 2010 | 190 | 0.320 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 181 | 0.320 |
Why?
| Injections, Intralesional | 2 | 2021 | 31 | 0.320 |
Why?
| Electrosurgery | 1 | 2008 | 7 | 0.310 |
Why?
| Time Factors | 6 | 2020 | 2903 | 0.310 |
Why?
| Fibrin Tissue Adhesive | 1 | 2008 | 12 | 0.310 |
Why?
| Tracheotomy | 2 | 2019 | 13 | 0.310 |
Why?
| Thyroid Neoplasms | 1 | 2009 | 110 | 0.300 |
Why?
| MicroRNAs | 2 | 2023 | 353 | 0.300 |
Why?
| Skin, Artificial | 1 | 2007 | 10 | 0.300 |
Why?
| Risk Factors | 7 | 2020 | 3613 | 0.300 |
Why?
| Hearing Loss, Unilateral | 3 | 2013 | 12 | 0.290 |
Why?
| Fasciitis, Necrotizing | 1 | 2006 | 7 | 0.290 |
Why?
| Atlanto-Axial Joint | 1 | 2006 | 7 | 0.290 |
Why?
| Tomography, X-Ray Computed | 6 | 2015 | 1159 | 0.280 |
Why?
| Emphysema | 1 | 2006 | 15 | 0.280 |
Why?
| Diet | 1 | 2010 | 566 | 0.280 |
Why?
| Arytenoid Cartilage | 2 | 2020 | 4 | 0.270 |
Why?
| Photography | 2 | 2020 | 32 | 0.270 |
Why?
| Disease Management | 3 | 2019 | 174 | 0.270 |
Why?
| Tinnitus | 1 | 2006 | 60 | 0.270 |
Why?
| Bone Conduction | 3 | 2017 | 26 | 0.270 |
Why?
| Recurrence | 5 | 2016 | 652 | 0.260 |
Why?
| Transcranial Magnetic Stimulation | 1 | 2006 | 70 | 0.260 |
Why?
| Esophagus | 3 | 2020 | 84 | 0.260 |
Why?
| Esophagoscopy | 2 | 2020 | 27 | 0.260 |
Why?
| Radiography | 2 | 2018 | 489 | 0.250 |
Why?
| Reoperation | 5 | 2014 | 454 | 0.250 |
Why?
| Gene Expression Regulation | 2 | 2020 | 976 | 0.240 |
Why?
| Pediatrics | 2 | 2019 | 279 | 0.230 |
Why?
| Fellowships and Scholarships | 2 | 2016 | 111 | 0.230 |
Why?
| Cross-Sectional Studies | 3 | 2022 | 1557 | 0.230 |
Why?
| Genetic Predisposition to Disease | 3 | 2019 | 510 | 0.230 |
Why?
| Patient Selection | 2 | 2019 | 253 | 0.230 |
Why?
| Single-Blind Method | 2 | 2020 | 116 | 0.220 |
Why?
| Diagnostic Imaging | 2 | 2017 | 176 | 0.220 |
Why?
| Cohort Studies | 5 | 2020 | 1422 | 0.220 |
Why?
| Antigens, Nuclear | 2 | 2013 | 24 | 0.220 |
Why?
| Treatment Failure | 2 | 2016 | 114 | 0.220 |
Why?
| Internship and Residency | 2 | 2020 | 443 | 0.220 |
Why?
| Mandible | 1 | 2023 | 21 | 0.210 |
Why?
| Magnetic Resonance Imaging | 5 | 2015 | 1537 | 0.210 |
Why?
| Transplantation, Heterologous | 2 | 2013 | 74 | 0.210 |
Why?
| Tracheal Stenosis | 2 | 2015 | 12 | 0.210 |
Why?
| Esthetics, Dental | 1 | 2022 | 21 | 0.210 |
Why?
| Vocal Cords | 1 | 2022 | 9 | 0.210 |
Why?
| Disease Progression | 3 | 2011 | 825 | 0.210 |
Why?
| Prognosis | 3 | 2018 | 1942 | 0.210 |
Why?
| Transforming Growth Factor beta1 | 1 | 2022 | 60 | 0.210 |
Why?
| Mice, Nude | 2 | 2013 | 252 | 0.210 |
Why?
| Immunoenzyme Techniques | 2 | 2013 | 143 | 0.210 |
Why?
| Nevus, Blue | 1 | 2022 | 12 | 0.200 |
Why?
| Comorbidity | 3 | 2015 | 615 | 0.200 |
Why?
| Respiratory Sounds | 2 | 2019 | 48 | 0.200 |
Why?
| Gastrointestinal Neoplasms | 1 | 2022 | 44 | 0.200 |
Why?
| Animals | 7 | 2019 | 13187 | 0.190 |
Why?
| Case-Control Studies | 2 | 2017 | 1131 | 0.190 |
Why?
| Middle Aged | 8 | 2022 | 12069 | 0.190 |
Why?
| Operating Rooms | 1 | 2021 | 26 | 0.190 |
Why?
| Nausea | 1 | 2021 | 50 | 0.190 |
Why?
| Efficiency, Organizational | 1 | 2021 | 42 | 0.190 |
Why?
| Air Microbiology | 1 | 2020 | 12 | 0.190 |
Why?
| Mouth Mucosa | 1 | 2020 | 25 | 0.190 |
Why?
| Thrombelastography | 1 | 2020 | 24 | 0.180 |
Why?
| DiGeorge Syndrome | 1 | 2020 | 20 | 0.180 |
Why?
| Hemostasis | 1 | 2020 | 55 | 0.180 |
Why?
| LIM Domain Proteins | 1 | 2020 | 7 | 0.180 |
Why?
| Reference Values | 2 | 2011 | 310 | 0.180 |
Why?
| Retinal Dehydrogenase | 1 | 2020 | 10 | 0.180 |
Why?
| Myosin Type I | 1 | 2020 | 5 | 0.180 |
Why?
| Antiporters | 1 | 2020 | 19 | 0.180 |
Why?
| Receptors, Notch | 1 | 2020 | 27 | 0.180 |
Why?
| Hearing Loss, Conductive | 2 | 2011 | 54 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 3 | 2013 | 1376 | 0.180 |
Why?
| Diagnosis, Differential | 3 | 2019 | 1037 | 0.180 |
Why?
| Pain, Postoperative | 1 | 2021 | 158 | 0.180 |
Why?
| Parasomnias | 1 | 2019 | 4 | 0.180 |
Why?
| Microsurgery | 2 | 2011 | 29 | 0.170 |
Why?
| Mastoid | 3 | 2009 | 51 | 0.170 |
Why?
| Cytoskeletal Proteins | 1 | 2020 | 49 | 0.170 |
Why?
| Tertiary Care Centers | 1 | 2020 | 77 | 0.170 |
Why?
| Physician Assistants | 1 | 2019 | 18 | 0.170 |
Why?
| Analysis of Variance | 2 | 2014 | 562 | 0.170 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 40 | 0.170 |
Why?
| Surgical Wound Infection | 1 | 2020 | 115 | 0.170 |
Why?
| Ambulatory Care | 1 | 2021 | 222 | 0.170 |
Why?
| Endothelium, Vascular | 1 | 2021 | 252 | 0.170 |
Why?
| Tetralogy of Fallot | 1 | 2020 | 86 | 0.170 |
Why?
| Mitochondrial Proteins | 1 | 2020 | 90 | 0.170 |
Why?
| Rats, Sprague-Dawley | 3 | 2009 | 1597 | 0.170 |
Why?
| Elastic Tissue | 1 | 2019 | 10 | 0.170 |
Why?
| Neovascularization, Pathologic | 1 | 2020 | 161 | 0.170 |
Why?
| Professional Role | 1 | 2019 | 76 | 0.170 |
Why?
| Nurse Practitioners | 1 | 2019 | 42 | 0.170 |
Why?
| Continuous Positive Airway Pressure | 1 | 2019 | 56 | 0.170 |
Why?
| Microcirculation | 1 | 2019 | 70 | 0.170 |
Why?
| Tryptases | 1 | 2018 | 4 | 0.160 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 197 | 0.160 |
Why?
| Sirolimus | 1 | 2019 | 62 | 0.160 |
Why?
| Age Factors | 3 | 2013 | 1087 | 0.160 |
Why?
| Dexamethasone | 1 | 2021 | 430 | 0.160 |
Why?
| p120 GTPase Activating Protein | 1 | 2018 | 1 | 0.160 |
Why?
| Fibrosis | 1 | 2019 | 179 | 0.160 |
Why?
| Port-Wine Stain | 1 | 2018 | 14 | 0.160 |
Why?
| Constriction, Pathologic | 1 | 2018 | 94 | 0.160 |
Why?
| Estrogen Receptor beta | 1 | 2018 | 54 | 0.160 |
Why?
| Cryosurgery | 1 | 2018 | 36 | 0.160 |
Why?
| Airway Extubation | 1 | 2018 | 30 | 0.160 |
Why?
| Random Allocation | 2 | 2009 | 281 | 0.160 |
Why?
| Estrogen Receptor alpha | 1 | 2018 | 89 | 0.150 |
Why?
| Protein Transport | 1 | 2018 | 180 | 0.150 |
Why?
| Ultrasonography, Doppler | 1 | 2018 | 42 | 0.150 |
Why?
| Optical Phenomena | 1 | 2017 | 11 | 0.150 |
Why?
| Neovascularization, Physiologic | 2 | 2009 | 68 | 0.150 |
Why?
| Palatine Tonsil | 1 | 2017 | 11 | 0.150 |
Why?
| Nanomedicine | 1 | 2017 | 21 | 0.150 |
Why?
| Transcriptome | 1 | 2020 | 315 | 0.150 |
Why?
| Faculty, Medical | 2 | 2019 | 89 | 0.150 |
Why?
| Pathology, Surgical | 1 | 2017 | 18 | 0.150 |
Why?
| Constipation | 1 | 2017 | 35 | 0.150 |
Why?
| Angiotensinogen | 1 | 2017 | 12 | 0.150 |
Why?
| Cadaver | 1 | 2017 | 97 | 0.150 |
Why?
| Pressure | 1 | 2017 | 105 | 0.150 |
Why?
| Peptidyl-Dipeptidase A | 1 | 2017 | 27 | 0.150 |
Why?
| Antibiotics, Antineoplastic | 1 | 2018 | 78 | 0.150 |
Why?
| Intubation, Intratracheal | 1 | 2018 | 118 | 0.140 |
Why?
| Diarrhea | 1 | 2017 | 92 | 0.140 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2017 | 57 | 0.140 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 169 | 0.140 |
Why?
| Mice | 3 | 2013 | 5739 | 0.140 |
Why?
| Middle Ear Ventilation | 1 | 2016 | 14 | 0.140 |
Why?
| Rats | 3 | 2009 | 3305 | 0.140 |
Why?
| Otitis Media with Effusion | 1 | 2016 | 15 | 0.140 |
Why?
| Child Behavior Disorders | 1 | 2017 | 79 | 0.140 |
Why?
| Mitochondria | 1 | 2020 | 402 | 0.140 |
Why?
| Child Behavior | 1 | 2017 | 106 | 0.140 |
Why?
| Food Hypersensitivity | 1 | 2017 | 100 | 0.140 |
Why?
| Serum | 1 | 2016 | 32 | 0.130 |
Why?
| Tobacco Smoke Pollution | 1 | 2016 | 48 | 0.130 |
Why?
| Drug Administration Schedule | 2 | 2013 | 376 | 0.130 |
Why?
| Hearing Loss | 1 | 2017 | 90 | 0.130 |
Why?
| Nasopharyngeal Diseases | 1 | 2015 | 4 | 0.130 |
Why?
| Anticoagulants | 1 | 2018 | 250 | 0.130 |
Why?
| Nasal Obstruction | 1 | 2015 | 13 | 0.130 |
Why?
| Urinary Bladder | 1 | 2015 | 92 | 0.120 |
Why?
| Inflammation | 1 | 2019 | 604 | 0.120 |
Why?
| Bandages, Hydrocolloid | 1 | 2014 | 4 | 0.120 |
Why?
| Gels | 1 | 2014 | 21 | 0.120 |
Why?
| Delphi Technique | 3 | 2020 | 46 | 0.120 |
Why?
| North America | 1 | 2014 | 64 | 0.120 |
Why?
| Endoscopy, Digestive System | 1 | 2014 | 50 | 0.120 |
Why?
| Apoptosis | 1 | 2020 | 1101 | 0.120 |
Why?
| Biopsy, Needle | 1 | 2015 | 183 | 0.120 |
Why?
| Early Diagnosis | 1 | 2014 | 88 | 0.120 |
Why?
| Foreign Bodies | 2 | 2020 | 65 | 0.120 |
Why?
| Sickness Impact Profile | 1 | 2014 | 28 | 0.120 |
Why?
| Administration, Oral | 2 | 2018 | 426 | 0.120 |
Why?
| Term Birth | 1 | 2013 | 16 | 0.120 |
Why?
| Aged | 4 | 2022 | 9310 | 0.120 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 32 | 0.120 |
Why?
| Hospitals, University | 1 | 2013 | 77 | 0.110 |
Why?
| Polysomnography | 1 | 2013 | 71 | 0.110 |
Why?
| Actins | 1 | 2013 | 118 | 0.100 |
Why?
| Bronchoscopy | 2 | 2010 | 71 | 0.100 |
Why?
| Algorithms | 1 | 2016 | 615 | 0.100 |
Why?
| Otologic Surgical Procedures | 2 | 2009 | 38 | 0.100 |
Why?
| Incidence | 2 | 2013 | 1003 | 0.100 |
Why?
| Pregnancy | 1 | 2019 | 2607 | 0.100 |
Why?
| Hearing Loss, Sensorineural | 1 | 2013 | 75 | 0.100 |
Why?
| Lymphocele | 1 | 2011 | 7 | 0.100 |
Why?
| Tissue Survival | 1 | 2011 | 10 | 0.100 |
Why?
| Antiviral Agents | 1 | 2013 | 173 | 0.100 |
Why?
| Statistics, Nonparametric | 2 | 2014 | 194 | 0.100 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 47 | 0.100 |
Why?
| Tissue Culture Techniques | 1 | 2011 | 40 | 0.100 |
Why?
| Education, Medical, Graduate | 1 | 2014 | 205 | 0.100 |
Why?
| Ultrasonography, Interventional | 1 | 2012 | 136 | 0.100 |
Why?
| Internet | 1 | 2014 | 259 | 0.100 |
Why?
| Liver | 1 | 2017 | 1115 | 0.100 |
Why?
| Arkansas | 3 | 2016 | 1977 | 0.100 |
Why?
| Lymphocytosis | 1 | 2011 | 4 | 0.100 |
Why?
| Laryngeal Edema | 1 | 2011 | 5 | 0.100 |
Why?
| Hypertrophy | 1 | 2011 | 50 | 0.090 |
Why?
| Brain | 1 | 2019 | 1328 | 0.090 |
Why?
| Nutritional Support | 1 | 2010 | 34 | 0.090 |
Why?
| Infant, Premature | 1 | 2013 | 318 | 0.090 |
Why?
| Lip Neoplasms | 1 | 2010 | 3 | 0.090 |
Why?
| Auditory Threshold | 1 | 2010 | 49 | 0.090 |
Why?
| Tracheal Diseases | 1 | 2010 | 12 | 0.090 |
Why?
| Thyroglossal Cyst | 1 | 2009 | 4 | 0.090 |
Why?
| Tongue Diseases | 1 | 2009 | 6 | 0.090 |
Why?
| Hospitals, Teaching | 1 | 2010 | 53 | 0.090 |
Why?
| Medical Records | 1 | 2010 | 83 | 0.090 |
Why?
| Vincristine | 1 | 2009 | 89 | 0.090 |
Why?
| Calcitonin | 1 | 2009 | 30 | 0.080 |
Why?
| Sensory Thresholds | 1 | 2009 | 17 | 0.080 |
Why?
| Granulation Tissue | 1 | 2009 | 10 | 0.080 |
Why?
| Blood Flow Velocity | 2 | 2020 | 101 | 0.080 |
Why?
| Lymphotoxin-alpha | 1 | 2009 | 8 | 0.080 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2009 | 69 | 0.080 |
Why?
| Tympanic Membrane | 1 | 2009 | 38 | 0.080 |
Why?
| Rhinitis | 1 | 2009 | 29 | 0.080 |
Why?
| Physical Examination | 1 | 2009 | 90 | 0.080 |
Why?
| Neoplasm Invasiveness | 1 | 2010 | 267 | 0.080 |
Why?
| Mucous Membrane | 1 | 2009 | 28 | 0.080 |
Why?
| Turner Syndrome | 1 | 2008 | 15 | 0.080 |
Why?
| Thyroidectomy | 1 | 2009 | 59 | 0.080 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 103 | 0.080 |
Why?
| Sinusitis | 1 | 2009 | 50 | 0.080 |
Why?
| Infusions, Intravenous | 1 | 2009 | 206 | 0.080 |
Why?
| Transplantation, Homologous | 1 | 2009 | 139 | 0.080 |
Why?
| Ear Diseases | 1 | 2008 | 26 | 0.080 |
Why?
| Burns, Electric | 1 | 2008 | 2 | 0.080 |
Why?
| Chi-Square Distribution | 1 | 2009 | 280 | 0.080 |
Why?
| Fires | 1 | 2008 | 13 | 0.080 |
Why?
| Suction | 1 | 2008 | 23 | 0.080 |
Why?
| Shock, Septic | 1 | 2009 | 78 | 0.080 |
Why?
| Sleep Apnea Syndromes | 1 | 2008 | 30 | 0.080 |
Why?
| Photomicrography | 1 | 2007 | 7 | 0.070 |
Why?
| Factor VII | 1 | 2007 | 3 | 0.070 |
Why?
| Hospitals, Pediatric | 2 | 2019 | 239 | 0.070 |
Why?
| Mouth Floor | 1 | 2007 | 5 | 0.070 |
Why?
| Polyvinyl Alcohol | 1 | 2007 | 9 | 0.070 |
Why?
| Postoperative Care | 1 | 2008 | 102 | 0.070 |
Why?
| Neoplasm Staging | 1 | 2010 | 740 | 0.070 |
Why?
| Collateral Circulation | 1 | 2007 | 39 | 0.070 |
Why?
| Biocompatible Materials | 1 | 2007 | 69 | 0.070 |
Why?
| Intraoperative Complications | 1 | 2008 | 112 | 0.070 |
Why?
| Auditory Cortex | 1 | 2006 | 22 | 0.070 |
Why?
| Patient Satisfaction | 1 | 2008 | 273 | 0.070 |
Why?
| Angiography | 1 | 2007 | 126 | 0.070 |
Why?
| Therapy, Computer-Assisted | 1 | 2006 | 30 | 0.070 |
Why?
| Thalamus | 1 | 2006 | 36 | 0.070 |
Why?
| Arousal | 1 | 2006 | 98 | 0.070 |
Why?
| Phenotype | 2 | 2019 | 729 | 0.070 |
Why?
| Swine | 1 | 2007 | 393 | 0.070 |
Why?
| Psychomotor Performance | 1 | 2006 | 130 | 0.070 |
Why?
| Reaction Time | 1 | 2006 | 216 | 0.070 |
Why?
| Attention | 1 | 2006 | 175 | 0.070 |
Why?
| Preoperative Care | 1 | 2007 | 164 | 0.070 |
Why?
| Radiopharmaceuticals | 1 | 2006 | 209 | 0.060 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2006 | 192 | 0.060 |
Why?
| Chronic Disease | 3 | 2016 | 567 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2009 | 486 | 0.060 |
Why?
| Positron-Emission Tomography | 1 | 2006 | 295 | 0.060 |
Why?
| United States | 4 | 2016 | 4860 | 0.060 |
Why?
| Mice, Inbred C57BL | 1 | 2009 | 1816 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2009 | 744 | 0.060 |
Why?
| Otitis Media | 2 | 2016 | 29 | 0.050 |
Why?
| Mutation | 2 | 2019 | 1294 | 0.050 |
Why?
| Growth Differentiation Factor 2 | 1 | 2022 | 6 | 0.050 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2023 | 86 | 0.050 |
Why?
| Transforming Growth Factor beta | 1 | 2022 | 144 | 0.050 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2022 | 78 | 0.050 |
Why?
| Esophagoscopes | 1 | 2020 | 1 | 0.050 |
Why?
| Blood Coagulation Tests | 1 | 2020 | 19 | 0.050 |
Why?
| Blood Coagulation | 1 | 2020 | 56 | 0.050 |
Why?
| Gastrostomy | 1 | 2020 | 55 | 0.040 |
Why?
| Ligands | 1 | 2020 | 204 | 0.040 |
Why?
| Exhalation | 1 | 2019 | 17 | 0.040 |
Why?
| Embryonic Development | 1 | 2019 | 17 | 0.040 |
Why?
| Fetus | 1 | 2021 | 217 | 0.040 |
Why?
| Genetic Loci | 1 | 2019 | 49 | 0.040 |
Why?
| Risk | 1 | 2020 | 320 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2019 | 89 | 0.040 |
Why?
| Income | 1 | 2019 | 99 | 0.040 |
Why?
| Syndrome | 1 | 2019 | 237 | 0.040 |
Why?
| Genetic Association Studies | 1 | 2019 | 117 | 0.040 |
Why?
| Hemorrhage | 1 | 2020 | 197 | 0.040 |
Why?
| Angiogenesis Inhibitors | 1 | 2020 | 187 | 0.040 |
Why?
| Double-Blind Method | 1 | 2020 | 681 | 0.040 |
Why?
| Gene Expression | 1 | 2021 | 609 | 0.040 |
Why?
| Comparative Genomic Hybridization | 1 | 2018 | 47 | 0.040 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2018 | 10 | 0.040 |
Why?
| Fibrinogen | 1 | 2018 | 31 | 0.040 |
Why?
| Tertiary Healthcare | 1 | 2017 | 16 | 0.040 |
Why?
| DNA-Binding Proteins | 1 | 2020 | 427 | 0.040 |
Why?
| Transcription Factors | 1 | 2020 | 561 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 274 | 0.030 |
Why?
| Triage | 1 | 2016 | 62 | 0.030 |
Why?
| Pain | 1 | 2018 | 379 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 577 | 0.030 |
Why?
| Quality-Adjusted Life Years | 1 | 2015 | 63 | 0.030 |
Why?
| Odds Ratio | 1 | 2016 | 545 | 0.030 |
Why?
| Patient-Centered Care | 1 | 2016 | 129 | 0.030 |
Why?
| Job Application | 1 | 2014 | 12 | 0.030 |
Why?
| Personnel Selection | 1 | 2014 | 24 | 0.030 |
Why?
| Logistic Models | 1 | 2016 | 888 | 0.030 |
Why?
| Personal Satisfaction | 1 | 2014 | 75 | 0.030 |
Why?
| Temporal Bone | 1 | 2013 | 35 | 0.030 |
Why?
| Patient Care Team | 1 | 2015 | 254 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2016 | 449 | 0.030 |
Why?
| Patient Admission | 1 | 2013 | 77 | 0.030 |
Why?
| Oximetry | 1 | 2013 | 67 | 0.030 |
Why?
| Program Evaluation | 1 | 2014 | 354 | 0.030 |
Why?
| Societies, Medical | 1 | 2013 | 175 | 0.020 |
Why?
| Decision Making | 1 | 2014 | 265 | 0.020 |
Why?
| Electrocardiography | 1 | 2013 | 257 | 0.020 |
Why?
| Referral and Consultation | 1 | 2013 | 285 | 0.020 |
Why?
| Blood Pressure | 1 | 2013 | 512 | 0.020 |
Why?
| Suture Anchors | 1 | 2010 | 11 | 0.020 |
Why?
| Fiber Optic Technology | 1 | 2010 | 16 | 0.020 |
Why?
| Blood Glucose | 1 | 2013 | 439 | 0.020 |
Why?
| Safety | 1 | 2010 | 78 | 0.020 |
Why?
| Prolapse | 1 | 2009 | 6 | 0.020 |
Why?
| Equipment Design | 1 | 2010 | 284 | 0.020 |
Why?
| Ear, Middle | 1 | 2008 | 19 | 0.020 |
Why?
| Demography | 1 | 2009 | 93 | 0.020 |
Why?
| Electric Power Supplies | 1 | 2008 | 1 | 0.020 |
Why?
| Acute Disease | 1 | 2009 | 366 | 0.020 |
Why?
| Drainage | 1 | 2008 | 78 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2015 | 3129 | 0.020 |
Why?
| Factor VIIa | 1 | 2007 | 9 | 0.020 |
Why?
| Postoperative Hemorrhage | 1 | 2007 | 51 | 0.020 |
Why?
| Survival Rate | 1 | 2008 | 894 | 0.020 |
Why?
| Length of Stay | 1 | 2009 | 619 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2007 | 486 | 0.020 |
Why?
|
|
Richter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|